Kaskela Law LLC is investigating Convey Health Solutions Holdings, Inc. (“Convey Health”) (NYSE: CNVY) on behalf of the company’s current stockholders.
On June18, 2021, Convey Health completed its initial public offering (“IPO”) of common stock, selling over 11.6 million shares of stock to investors at a price of $14.00 per share. By May 2022, shares of Convey Health’s stock had declined in value to approximately $5.00 per share.
On June 21, 2022, Convey Health announced that it had agreed to be acquired by private equity firm TPG at a price of $10.50 per share. Following the closing of the proposed transaction, CNVY’s shareholders will be cashed out of their investment position, and the company’s shares will no longer be publicly traded.
The investigation seeks to determine: (i) whether the transaction is fair to Convey Health shareholders; (ii) whether Convey Health shareholders will be receiving sufficient monetary consideration for their shares; and (iii) whether Convey Health’s directors have breached their fiduciary duties to the company’s stockholders in agreeing to sell the company to TPG.
Convey Health shareholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by email ([email protected]) or by completing the form on this page, for additional information about this investigation and their legal rights and options.